| | | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
|---|
|
|
| | | | | | Avtozma 162mg/0.9 ml | | PA | PA | k.A. | | | iQone Healthcare
Switzerland SA | A | FB | | G |  |
| | | | | | Avtozma 162 mg/0.9 ml | | PA | PA | k.A. | | | iQone Healthcare
Switzerland SA | A | FB | | G | |
| | | | | | Avtozma 162mg/0.9 ml | 4 | PA | PA | k.A. | | | iQone Healthcare
Switzerland SA | A | FB | | G | |
| | | | | | Avtozma 162 mg/0.9 ml | 4 | PA | PA | k.A. | | | iQone Healthcare
Switzerland SA | A | FB | | G | |
| | | | | | Mounjaro KwikPen 2.5 mg | 4 | PA | PA | k.A. | | | Eli Lilly (Suisse) SA | B | FB | | G | |
| | | | | | Mounjaro KwikPen 5 mg | 4 | PA | PA | k.A. | | | Eli Lilly (Suisse) SA | B | FB | | G | |
| | | | | | Mounjaro KwikPen 7.5 mg | 4 | PA | PA | k.A. | | | Eli Lilly (Suisse) SA | B | FB | | G | |
| | | | | | Mounjaro KwikPen 10 mg | 4 | PA | PA | k.A. | | | Eli Lilly (Suisse) SA | B | FB | | G | |
| | | | | | Mounjaro KwikPen 12.5 mg | 4 | PA | PA | k.A. | | | Eli Lilly (Suisse) SA | B | FB | | G | |
| | | | | | Mounjaro KwikPen 15 mg | 4 | PA | PA | k.A. | | | Eli Lilly (Suisse) SA | B | FB | | G | |
| | | | | | Eribulin Advanz Pharma
0.44 mg/ml | | PA | PA | k.A. | | Injektionslösung: Eribulinum | Advanz Pharma
Specialty Medicine
Switzerland GmbH | A | FB | | G | |
| | | | | | IMCIVREE 10 mg/ml | | PA | PA | k.A. | | Injektionslösung: Setmelanotidum 10 mg/ml | pharma services
Oehler GmbH | B | FB | | G | |
| | | | | | Pavblu 40 mg/ml | | PA | PA | k.A. | | Injektionslösung: Afliberceptum 2mg / 0.05ml | Amgen Switzerland AG | B | FB | | G | |
| | | | | | Pavblu 40 mg/ml | | PA | PA | k.A. | | Injektionslösung in Fertigspritze: Afliberceptum 2mg / 0.05ml | Amgen Switzerland AG | B | FB | | G | |
| | | | | | Solifenacin Leman ODT 5 mg | 30 | PA | PA | k.A. | | Schmelztabletten: Solifenacini Succinas 5 mg | Leman SKL SA | B | FB | | G | |
| | | | | | Solifenacin Leman ODT 5 mg | 90 | PA | PA | k.A. | | Schmelztabletten: Solifenacini Succinas 5 mg | Leman SKL SA | B | FB | | G | |
| | | | | | Solifenacin Leman ODT 10 mg | 30 | PA | PA | k.A. | | Schmelztabletten: Solifenacini Succinas 10 mg | Leman SKL SA | B | FB | | G | |
| | | | | | Solifenacin Leman ODT 10 mg | 90 | PA | PA | k.A. | | Schmelztabletten: Solifenacini Succinas 10 mg | Leman SKL SA | B | FB | | G | |
| | | | | | Avtozma 80 mg/ 4ml | | PA | PA | k.A. | | Infusionskonzentrat: Tocilizumabum 80mg / 10ml | iQone Healthcare
Switzerland SA | A | FB | | G | |
| | | | | | Avtozma 200 mg/10 ml | | PA | PA | k.A. | | Infusionskonzentrat: Tocilizumabum 200mg / 10ml | iQone Healthcare
Switzerland SA | A | FB | | G | |
| | | | | | Avtozma 400 mg/20 ml | | PA | PA | k.A. | | Infusionskonzentrat: Tocilizumabum 400mg / 20ml | iQone Healthcare
Switzerland SA | A | FB | | G | |
| | | FI | | | Tremfya 200 mg/20 ml | | PA | PA | k.A. | | Infusionskonzentrat: Guselkumabum 200mg / 20ml | Janssen-Cilag AG | B | FB | | G | |
| | | | | | ZYNYZ 500 mg/20 ml | | PA | PA | k.A. | | Infusionskonzentrat: Retifanlimabum 500mg / 20ml | Incyte Biosciences
International Sàrl | A | FB | | G | |
| | | | | CM | LIVSANE Junior Schnupfen
Xylo 0.05 % | 10 ml | PA | PA | k.A. | | Nasenspray: Xylometazolini Hydrochloridum | Pharmapost AG | D | FB | | G | |
| | | | | CM | LIVSANE Schnupfen Xylo 0.1 % | 10 ml | PA | PA | k.A. | | Nasenspray: Xylometazolini Hydrochloridum 1 mg/ml/ml | Pharmapost AG | D | FB | | G | |
| | | | | CM | LIVSANE Xylo PLUS | 10 ml | PA | PA | k.A. | | Nasenspray: 2 Wirkstoffe | Pharmapost AG | D | FB | | G | |
| | | | | | Ryaltris 25 μg / 600 μg | 56 | PA | PA | k.A. | | Nasenspray: Mometasoni Furoas | NOBEL Pharma Schweiz AG | B | FB | | G | |
| | | | | | Ryaltris 25 μg / 600 μg | 120 | PA | PA | k.A. | | Nasenspray: Mometasoni Furoas | NOBEL Pharma Schweiz AG | B | FB | | G | |
| | | | | | Ryaltris 25 μg / 600 μg | 240 | PA | PA | k.A. | | Nasenspray: Mometasoni Furoas | NOBEL Pharma Schweiz AG | B | FB | | G | |
| | | | | CM | Atorvastatin Aspen 10 mg | 30 | PA | PA | k.A. | | Filmtabletten: Atorvastatinum 10 mg | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | | | CM | Atorvastatin Aspen 10 mg | 100 | PA | PA | k.A. | | Filmtabletten: Atorvastatinum 10 mg | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | | | CM | Atorvastatin Aspen 20 mg | 30 | PA | PA | k.A. | | Filmtabletten: Atorvastatinum 20 mg | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | | | CM | Atorvastatin Aspen 20 mg | 100 | PA | PA | k.A. | | Filmtabletten: Atorvastatinum 20 mg | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | | | CM | Atorvastatin Aspen 40 mg | 30 | PA | PA | k.A. | | Filmtabletten: Atorvastatinum 40 mg | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | | | CM | Atorvastatin Aspen 40 mg | 100 | PA | PA | k.A. | | Filmtabletten: Atorvastatinum 40 mg | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | | | CM | Atorvastatin Aspen 80 mg | 30 | PA | PA | k.A. | | Filmtabletten: Atorvastatinum 80 mg | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | | | CM | Atorvastatin Aspen 80 mg | 100 | PA | PA | k.A. | | Filmtabletten: Atorvastatinum 80 mg | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | | | CM | Bisoprolol Aspen 2.5 mg | 100 | PA | PA | k.A. | | Filmtabletten: Bisoprololi Fumaras 2.5 mg | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | | | CM | Bisoprolol Aspen 5 mg | 30 | PA | PA | k.A. | | Filmtabletten: Bisoprololi Fumaras 5 mg | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | | | CM | Bisoprolol Aspen 10 mg | 30 | PA | PA | k.A. | | Filmtabletten: Bisoprololi Fumaras 10 mg | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | | | | Pazopanib Sandoz 200 mg | 30 | PA | PA | k.A. | | Filmtabletten: Pazopanibum 200 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | | | | Pazopanib Sandoz 400 mg | 60 | PA | PA | k.A. | | Filmtabletten: Pazopanibum 400 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | | | | Prasugrel Spirig HC 5 mg | 28 | PA | PA | k.A. | | Filmtabletten: Prasugrelum 5 mg | Spirig HealthCare AG | B | FB | | G | |
| | | | | | Prasugrel Spirig HC 5 mg | 98 | PA | PA | k.A. | | Filmtabletten: Prasugrelum 5 mg | Spirig HealthCare AG | B | FB | | G | |
| | | | | | Prasugrel Spirig HC 10 mg | 28 | PA | PA | k.A. | | Filmtabletten: Prasugrelum 10 mg | Spirig HealthCare AG | B | FB | | G | |
| | | | | | Prasugrel Spirig HC 10 mg | 98 | PA | PA | k.A. | | Filmtabletten: Prasugrelum 10 mg | Spirig HealthCare AG | B | FB | | G | |
| | | FI | PI | | Tofacitinib Devatis 5 mg | 56 | PA | PA | k.A. | | Filmtabletten: Tofacitinibum 5 mg | Devatis AG | B | FB | | G | |
| | | FI | | | Tofacitinib Devatis 10 mg | 56 | PA | PA | k.A. | | Filmtabletten: Tofacitinibum 10 mg | Devatis AG | B | FB | | G | |
| | | | | | Tranexamic OrPha 500 mg | 30 | PA | PA | k.A. | | Filmtabletten: Acidum Tranexamicum 500 mg | OrPha Swiss GmbH | B | FB | | G | |
| | | | | | Ifinwil 192 mg | 100 | PA | PA | k.A. | | Tabletten: Eflornithini Hydrochloridum Monohydricum 250 mg | Norgine AG | A | FB | | G | |
| | | | | | Abilify Asimtufii 720 mg | | PA | PA | k.A. | | Depot-Injektionssuspension in einer Fertigspritze: Aripiprazolum 720mg / 2.4ml | Lundbeck (Schweiz) AG | B | FB | | G | |
| | | | | | Abilify Asimtufii 960 mg | | PA | PA | k.A. | | Depot-Injektionssuspension in einer Fertigspritze: Aripiprazolum 960mg / 3.2ml | Lundbeck (Schweiz) AG | B | FB | | G | |
| | | | | | Betolo | 24 | PA | PA | k.A. | | Lutschtabletten mit Honig-Zitronengeschmack: 3 Wirkstoffe | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | D | FB | | G | |
| | | | | | Betolo | 24 | PA | PA | k.A. | | Lutschtabletten mit Minzgeschmack: 3 Wirkstoffe | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | D | FB | | G | |
| | | | | | Betolo | 24 | PA | PA | k.A. | | Lutschtabletten mit Orangengeschmack: 3 Wirkstoffe | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | D | FB | | G | |
| | | | | | Blenrep 70 mg | | PA | PA | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Belantamabum Mafodotinum 70 mg | GlaxoSmithKline AG | A | FB | | G | |
| | | | | | Blenrep 100 mg | | PA | PA | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Belantamabum Mafodotinum 100 mg | GlaxoSmithKline AG | A | FB | | G | |
| | | | | | Betolo | 20 ml | PA | PA | k.A. | | Spray zur Anwendung in der Mundhöhle: 3 Wirkstoffe | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | D | FB | | G | |
| | | | | | Dexocol 1 mg/ml | 6 ml | PA | PA | k.A. | | collyre en solution: Dexamethasoni Dihydrogenophosphas 1 mg/ml | Horus Pharma Suisse SA | A | FB | | G | |
| | | | | | Dexocol 1 mg/ml | 3 x 6 ml | PA | PA | k.A. | | collyre en solution: Dexamethasoni Dihydrogenophosphas 1 mg/ml | Horus Pharma Suisse SA | A | FB | | G | |
| | | | | | Remifentanil Leman IV 1 mg | 5 | PA | PA | k.A. | | poudre pour solution à diluer pour perfusion: Remifentanilum 1 mg | Leman SKL SA | A+ | FB | | G | |
| | | | | | Remifentanil Leman IV 2 mg | 5 | PA | PA | k.A. | | poudre pour solution à diluer pour perfusion: Remifentanilum 2 mg | Leman SKL SA | A+ | FB | | G | |
| | | | | | Remifentanil Leman IV 5 mg | 5 | PA | PA | k.A. | | poudre pour solution à diluer pour perfusion: Remifentanilum 5 mg | Leman SKL SA | A+ | FB | | G | |
| | | | | | Phenylephrin Aguettant 0,1
mg/ml | 10 x 20 ml | PA | PA | k.A. | | solution injectable/pour perfusion: Phenylephrinum | Aguettant Suisse SA | B | FB | | G | |
| | | FI | | | Noradrenalin Sintetica
Ultradiluted 0,01 mg/ml | 50 ml | PA | PA | k.A. | | soluzione iniettabile o per infusione: Noradrenalinum | Sintetica SA | B | FB | | G | |
| | | FI | | | Noradrenalin Sintetica
Ultradiluted 0,02 mg/ml | 50 ml | PA | PA | k.A. | | soluzione iniettabile o per infusione: Noradrenalinum | Sintetica SA | B | FB | | G | |
